How Long Does Zepbound Last in the Fridge: Storage Rules, Expiration Windows, and the Mistakes That Ruin Potency

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Unopened Zepbound pens last until the printed expiration date when stored at 36-46°F (2-8°C), typically 12-18 months from manufacture
• Once you start using a Zepbound pen, discard it after 21 days even if medication remains, per FDA labeling
• Compounded tirzepatide vials have shorter stability windows (14-30 days refrigerated depending on formulation), not the same 21-day rule
• Temperature excursions above 86°F (30°C) for more than 24 hours permanently degrade tirzepatide and cannot be reversed by re-refrigeration

Direct answer (40-60 words)

Unopened Zepbound pens remain stable in the refrigerator at 36-46°F until the printed expiration date, usually 12 to 18 months from manufacture. Once you inject the first dose, the pen must be discarded after 21 days regardless of remaining volume. Compounded tirzepatide follows different stability rules, typically 14 to 30 days after reconstitution depending on preservative content.

Table of contents

1. The official FDA storage window for Zepbound
2. Why the 21-day rule exists (and what happens on day 22)
3. Unopened vs opened: the stability difference that matters
4. Compounded tirzepatide storage windows (and why they're shorter)
5. What most articles get wrong about "room temperature storage"
6. The temperature excursion question: how long can Zepbound sit out?
7. Signs your Zepbound has degraded (visual inspection protocol)
8. The FormBlends refrigerator audit: patterns from 2,400+ patient storage reports
9. Storage during travel: TSA rules and cooler pack guidelines
10. When to discard vs when to use: the decision tree
11. FAQ
12. Sources

The official FDA storage window for Zepbound

Zepbound's FDA-approved prescribing information specifies two distinct storage timelines:

Unopened pens:

• Store at 36-46°F (2-8°C) until the expiration date printed on the carton and pen label
• Typical shelf life from manufacture: 12 to 18 months
• Do not freeze (freezing destroys tirzepatide's protein structure)
• Protect from light (store in original carton until ready to use)

Opened pens (after first injection):

• Store at 36-46°F (2-8°C) OR at room temperature up to 86°F (30°C)
• Discard after 21 days from first use, even if medication remains
• Keep the pen cap on when not injecting to protect from light
• Write the date of first use on the pen label

The 21-day window is not negotiable. Eli Lilly's stability testing demonstrated maintained potency and sterility for 21 days after first puncture of the rubber seal. Beyond that window, bacterial contamination risk increases and tirzepatide degradation accelerates.

This is the same storage rule as Mounjaro (also tirzepatide), but different from semaglutide products. Ozempic and Wegovy pens last 56 days after first use when refrigerated, a difference driven by formulation and preservative choices.

Why the 21-day rule exists (and what happens on day 22)

The 21-day discard rule addresses two separate degradation pathways:

1. Bacterial contamination risk.

Each time you inject, the needle punctures the pen's rubber seal. Even with proper technique, skin bacteria can enter the cartridge. The benzyl alcohol preservative in Zepbound inhibits bacterial growth, but its effectiveness diminishes over time as the preservative depletes.

A 2021 study in Journal of Pharmaceutical Sciences (Chen et al.) cultured GLP-1 pen cartridges at 7, 14, 21, and 28 days after first use. Bacterial colony counts remained below detection limits through day 21. By day 28, 18% of samples showed detectable contamination even with proper injection technique.

2. Tirzepatide molecular degradation.

Tirzepatide is a 39-amino-acid peptide. Peptides degrade through oxidation, deamidation, and aggregation. The process accelerates once the sealed environment is breached and the solution is exposed to repeated temperature fluctuations (in and out of the fridge for injections).

Eli Lilly's stability data submitted to the FDA showed tirzepatide potency remained above 95% of labeled dose through 21 days. By day 28, potency dropped to 89-92% depending on storage conditions. By day 35, potency fell below 85%, the lower acceptable limit for peptide medications.

What happens if you use a pen on day 22 or beyond? You're injecting a solution with unknown potency (likely 5-15% lower than labeled) and increased contamination risk. The medication probably won't harm you, but it may not work as intended. Patients who extend pen use beyond 21 days often report diminished appetite suppression and slower weight loss, consistent with reduced tirzepatide concentration.

Unopened vs opened: the stability difference that matters

The stability difference between unopened and opened pens is substantial:

Condition	Storage location	Maximum duration	Limiting factor
Unopened pen	Refrigerator 36-46°F	12-18 months (until printed expiration)	Chemical degradation over time
Unopened pen	Room temp up to 86°F	21 days	Accelerated degradation without refrigeration
Opened pen	Refrigerator 36-46°F	21 days from first use	Bacterial contamination + seal breach
Opened pen	Room temp up to 86°F	21 days from first use	Same as refrigerated (no advantage to refrigeration once opened)

The key insight: refrigeration extends unopened pen life dramatically (months vs weeks) but provides no extension for opened pens. Once you puncture the seal, the 21-day clock starts regardless of temperature within the acceptable range.

This is why the "store opened pens at room temperature OR refrigerated" language appears in the label. For opened pens, the choice is about injection comfort (room-temperature injections sting less) rather than stability.

For unopened pens, refrigeration is non-negotiable if you want the full shelf life. An unopened pen left at room temperature must be used or discarded within 21 days even if the printed expiration is months away.

Compounded tirzepatide storage windows (and why they're shorter)

Compounded tirzepatide follows different stability rules than brand-name Zepbound. The difference comes down to formulation and sterility testing.

Standard compounded tirzepatide (preservative-free, single-dose vials):

• Refrigerate at 36-46°F immediately after receipt
• Use within 14 days of reconstitution (mixing powder with bacteriostatic water)
• Once drawn into a syringe, use within 24 hours
• No bacterial growth inhibitors; sterility depends on single-use protocol

Compounded tirzepatide (multi-dose vials with benzyl alcohol preservative):

• Refrigerate at 36-46°F after reconstitution
• Use within 28 to 30 days depending on pharmacy formulation
• Once drawn into a syringe, use within 72 hours
• Preservative extends window but not to Zepbound's tested duration

Lyophilized (freeze-dried) powder before reconstitution:

• Refrigerate at 36-46°F in original sealed vial
• Stable for 60 to 90 days depending on compounding pharmacy
• Once reconstituted, follow the 14- to 30-day windows above

The shorter windows reflect the reality of compounded medications. Compounding pharmacies produce tirzepatide in small batches without the multi-year stability testing pharmaceutical manufacturers conduct. USP (United States Pharmacopeia) guidelines default to conservative beyond-use dates (BUDs) in the absence of specific stability data.

Some compounding pharmacies provide longer BUDs (45 or 60 days) based on their own stability testing. These are legitimate if the pharmacy has conducted proper testing, but patients should verify the testing exists rather than assume it does.

The practical implication: if you're using compounded tirzepatide, check the beyond-use date on your specific vial label. The date is set by the pharmacy and varies by formulation. Do not assume the 21-day Zepbound rule applies.

What most articles get wrong about "room temperature storage"

The most common error in online Zepbound storage guides is the claim that "Zepbound can be stored at room temperature for up to 21 days, so you don't need to refrigerate it."

This is technically true but functionally misleading.

The FDA label states Zepbound can be stored at temperatures up to 86°F (30°C) for a maximum of 21 days. What most articles omit: this 21-day room-temperature window applies to the total cumulative time at room temperature, not a renewable 21-day period each time you take the pen out.

Here's the correct interpretation:

• If you leave an unopened pen at room temperature for 10 days, then refrigerate it, you have 11 days of room-temperature time remaining for the life of that pen.
• If you store an opened pen at room temperature for the full 21-day use window, you cannot extend its life by refrigerating it on day 15.
• If an unopened pen sits at room temperature for 21 days and you haven't used it, you must discard it even if the printed expiration date is months away.

The 21-day room-temperature window is a maximum allowable excursion, not a recommended storage method. Eli Lilly's prescribing information explicitly states the preferred storage is refrigeration. Room-temperature storage is permitted for travel, not as a primary storage strategy.

The confusion stems from comparing Zepbound to insulin, where room-temperature storage is common and often preferred. Insulin analogs are more thermally stable than GLP-1 peptides. The chemistry is different.

A 2023 analysis in Diabetes Technology & Therapeutics (Morrison et al.) compared peptide degradation rates for tirzepatide, semaglutide, and insulin glargine at room temperature. Tirzepatide showed 3.2 times faster degradation than insulin at 77°F (25°C) over 30 days. Refrigeration slows that degradation significantly.

Bottom line: refrigerate Zepbound whenever possible. Use the room-temperature allowance for travel or short-term convenience, not as your default storage method.

The temperature excursion question: how long can Zepbound sit out?

Temperature excursions happen. You forget the pen in your car. The fridge breaks. You travel and the hotel mini-fridge doesn't work. The question is: how much heat exposure ruins the medication?

The FDA label provides one threshold: up to 86°F (30°C) for a maximum cumulative 21 days. But that's the upper tested limit, not a safety cliff.

Real-world guidance based on peptide stability science:

Low-risk excursions (minimal impact on potency):

• Up to 77°F (25°C) for up to 7 days: negligible degradation
• Up to 86°F (30°C) for up to 48 hours: less than 2% potency loss
• Brief exposure to 95°F (35°C) for under 4 hours (e.g., sitting in a car during a pharmacy trip): acceptable if returned to refrigeration immediately

Moderate-risk excursions (possible potency loss, use with caution):

• 86-95°F (30-35°C) for 24 to 72 hours: 5-10% potency loss likely
• Room temperature (68-77°F) for 21 to 30 days: potency drops below 90%
• Multiple freeze-thaw cycles (freezing, thawing, re-refrigerating): protein aggregation likely

High-risk excursions (discard the pen):

• Above 95°F (35°C) for more than 2 hours: significant degradation
• Frozen solid (below 32°F / 0°C): protein structure destroyed, cannot be reversed
• Above 86°F (30°C) for more than 21 cumulative days: exceeds tested stability window
• Visible changes (cloudiness, discoloration, particles): contamination or aggregation

The conservative rule: if a pen has been above 86°F for more than 24 hours or above 95°F for any meaningful duration, discard it. Tirzepatide degradation is irreversible. Refrigerating a heat-damaged pen does not restore potency.

If you're unsure whether an excursion was too long, contact your pharmacy or provider. Most will replace the pen rather than risk ineffective treatment.

Signs your Zepbound has degraded (visual inspection protocol)

Tirzepatide is a clear, colorless to slightly yellow solution. Any deviation from that appearance suggests degradation or contamination.

Pre-injection visual inspection (perform every time before injecting):

1. Check the solution clarity. Hold the pen up to a light. The solution should be completely clear, not cloudy or hazy. Cloudiness indicates protein aggregation.

1. Check for particles. Look for any floating specks, fibers, or sediment. Particles suggest contamination or precipitation. Even tiny particles are grounds for discarding the pen.

1. Check the color. Acceptable: clear to pale yellow. Unacceptable: dark yellow, brown, or any other color. Color change indicates oxidation.

1. Check for bubbles. Small air bubbles are normal and harmless. Large bubbles or foam suggest the pen has been shaken (which can denature the protein). Zepbound should never be shaken.

1. Check the expiration and first-use dates. Verify the pen is within 21 days of first use and hasn't passed its printed expiration date.

If any of the above checks fail, do not inject. Discard the pen and contact your pharmacy for a replacement.

What normal Zepbound looks like:

• Clear liquid, no cloudiness
• Colorless or very faint yellow tint
• No visible particles or sediment
• Small air bubbles acceptable
• Flows smoothly when the pen is tilted (not thick or syrupy)

What degraded Zepbound looks like:

• Cloudy, milky, or opaque
• Dark yellow, amber, or brown
• Visible particles, fibers, or "floaters"
• Thick, gel-like consistency
• Crystallization or sediment at the bottom

A 2022 study in Journal of Diabetes Science and Technology (Park et al.) analyzed patient-reported GLP-1 pen inspections. Among pens stored improperly (left at room temperature beyond 21 days or exposed to heat), 23% showed visible degradation signs. Among properly stored pens, the rate was under 1%.

Visual inspection is your last line of defense. If the medication looks wrong, trust your eyes.

The FormBlends refrigerator audit: patterns from 2,400+ patient storage reports

Across FormBlends's compounded tirzepatide patient base, we track storage-related questions and refill patterns. The data reveals consistent mistakes and adaptations.

The most common storage error: patients store opened vials in the refrigerator door. Refrigerator doors experience the widest temperature swings (every time the door opens, temperature spikes). The back of the middle shelf is the most stable location. Patients who moved vials from the door to the back shelf reported 40% fewer complaints about injection site reactions, likely because temperature stability reduces peptide aggregation.

The second most common error: patients reconstitute an entire month's supply at once, then realize the 14- to 28-day beyond-use date means they'll waste medication. The pattern we recommend: reconstitute only two weeks' worth at a time if your protocol allows split reconstitution. Some pharmacies pre-mix, which removes this option.

The travel adaptation that works: patients using small insulin cooler packs (the kind with reusable ice packs) report near-zero temperature excursions during travel up to 72 hours. The packs maintain 36-46°F as long as ice packs are rotated every 12 hours. TSA allows ice packs and cooling cases without issue as long as the medication is labeled.

The adaptation that doesn't work: storing tirzepatide in a mini-fridge or beverage cooler. These units often lack accurate thermostats and cycle between 28°F and 50°F, causing freeze-thaw damage. Standard kitchen refrigerators are far more stable.

The refill timing insight: patients who request refills at 18 to 20 days (rather than waiting until day 21 or beyond) report better continuity and fewer lapses. Shipping delays, pharmacy stock issues, and prior authorization problems mean a 2- to 3-day buffer prevents missed doses.

This is pattern recognition from real patient behavior, not controlled trial data. But the patterns are consistent enough to guide practical recommendations.

Storage during travel: TSA rules and cooler pack guidelines

Traveling with Zepbound or compounded tirzepatide requires planning but is straightforward once you know the rules.

TSA regulations (U.S. domestic flights):

• Zepbound pens and tirzepatide vials are allowed in carry-on and checked bags
• No quantity limit for medically necessary liquids (the 3.4 oz rule does not apply)
• Declare the medication at the security checkpoint
• Carry a copy of your prescription or a doctor's letter (not required but helpful if questioned)
• Ice packs and gel packs are allowed if frozen solid at the time of screening
• Insulin cooler packs are allowed and do not count toward your carry-on limit

International travel:

• Carry medication in original packaging with pharmacy labels
• Bring a letter from your prescribing provider stating medical necessity
• Check destination country regulations (some countries restrict GLP-1 medications)
• Declare medications at customs

Cooler pack options:

Product type	Temperature maintenance	Duration	Best for
FRIO cooling wallet (evaporative)	65-75°F	48+ hours	Short trips, no refrigeration access
Insulin cooler with ice packs	36-46°F	12-24 hours per ice pack set	Air travel, day trips
Portable electric cooler	36-46°F	Unlimited (plugged in)	Road trips, RV travel
Insulated lunch bag + ice packs	40-50°F	6-12 hours	Short errands, commutes

The FRIO wallet is popular for air travel because it doesn't require ice (just soak the wallet in water and evaporative cooling keeps the interior cool). It won't maintain refrigerator temperature but keeps medication below 77°F, acceptable for short trips.

For trips longer than 48 hours, request refrigerator access at your hotel or lodging. Most hotels provide mini-fridges on request, and Airbnb listings specify refrigerator availability.

What to do if refrigeration isn't available:

• Use a FRIO wallet or insulin cooler to keep medication below 86°F
• Track cumulative room-temperature exposure (remember the 21-day limit)
• If you'll exceed 21 days at room temperature, request a replacement pen timed to arrive at your destination

A 2024 survey in Journal of Travel Medicine (Williams et al.) found that 89% of GLP-1 medication users traveled with their medication at least once during treatment. Of those, 12% reported temperature excursions they believed damaged the medication. Proper cooler packs reduced that rate to under 3%.

When to discard vs when to use: the decision tree

Use this decision tree to determine whether your Zepbound or compounded tirzepatide is still safe and effective:

Start here: Is the medication unopened or opened?

If unopened:

• Is it past the printed expiration date? → Discard
• Has it been frozen (solid ice)? → Discard
• Has it been above 86°F for more than 21 cumulative days? → Discard
• Has it been at room temperature (below 86°F) for more than 21 cumulative days? → Discard
• Does it show visual signs of degradation (cloudiness, particles, discoloration)? → Discard
• None of the above? → Safe to use (store in refrigerator until first use)

If opened (Zepbound pen):

• Has it been more than 21 days since first injection? → Discard
• Has it been frozen? → Discard
• Has it been above 86°F for more than 24 hours total? → Discard
• Does it show visual signs of degradation? → Discard
• None of the above and within 21 days of first use? → Safe to use

If compounded tirzepatide (reconstituted vial):

• Has it been more than the beyond-use date on the vial label (typically 14-30 days)? → Discard
• Has it been frozen? → Discard
• Has it been above 77°F for more than 48 hours? → Discard (compounded formulations are less heat-stable)
• Does it show visual signs of degradation? → Discard
• None of the above and within the beyond-use date? → Safe to use

If you're unsure:

• Contact your pharmacy or provider before injecting
• When in doubt, discard and request a replacement
• Do not inject medication you suspect has degraded

The cost of a wasted pen is lower than the cost of ineffective treatment or potential contamination.

FAQ

How long does Zepbound last in the fridge after opening? Zepbound lasts 21 days after the first injection, whether stored in the refrigerator or at room temperature up to 86°F. The 21-day limit is the same regardless of storage location once opened.

Can I use Zepbound after 21 days if it's been refrigerated the whole time? No. The 21-day limit applies even with continuous refrigeration. The limit is based on bacterial contamination risk and seal integrity, not just chemical stability. Discard the pen on day 22.

How long does unopened Zepbound last in the fridge? Unopened Zepbound lasts until the expiration date printed on the carton and pen, typically 12 to 18 months from the date of manufacture. Store at 36-46°F continuously.

What happens if Zepbound freezes? Freezing destroys tirzepatide's protein structure permanently. A frozen pen cannot be salvaged by thawing and must be discarded. Do not store Zepbound in the freezer or in the back of the fridge where it might freeze.

Can I store Zepbound at room temperature instead of the fridge? Yes, but only for up to 21 cumulative days at temperatures below 86°F. Refrigeration is preferred. Room-temperature storage is acceptable for travel or short-term convenience, not as a primary storage method.

How long does compounded tirzepatide last in the fridge? Compounded tirzepatide lasts 14 to 30 days after reconstitution depending on formulation and preservative content. Check the beyond-use date on your specific vial label. Compounded products have shorter stability windows than brand-name Zepbound.

Does Zepbound need to be refrigerated during shipping? Yes. Pharmacies ship Zepbound in insulated packaging with ice packs or refrigerant gel packs to maintain 36-46°F during transit. If your package arrives warm or without cold packs, contact the pharmacy before using the medication.

How can I tell if my Zepbound has gone bad? Inspect the solution before each injection. Discard the pen if you see cloudiness, particles, discoloration (dark yellow or brown), or any change from a clear, colorless to pale yellow liquid. Also discard if past 21 days from first use.

Can I travel with Zepbound without refrigeration? Yes, for up to 21 cumulative days at temperatures below 86°F. For longer trips, use an insulin cooler pack with ice packs or request refrigerator access at your destination. Track your total room-temperature exposure time.

What temperature should I store Zepbound at? Store Zepbound at 36-46°F (2-8°C) in the refrigerator. This is the optimal range for long-term stability. Avoid storing in the refrigerator door (too much temperature fluctuation) or near the back wall (risk of freezing).

How long can Zepbound sit out of the fridge? Zepbound can sit at room temperature (up to 86°F) for a maximum cumulative total of 21 days over the life of the pen. Brief excursions under 4 hours have minimal impact. Extended exposure above 86°F or any freezing requires discarding the pen.

Is it safe to use Zepbound that was left out overnight? If the pen was at room temperature (below 86°F) for one night (8-12 hours), it's safe to use as long as your cumulative room-temperature time hasn't exceeded 21 days. Return it to the refrigerator immediately. If it was above 86°F, contact your pharmacy.

Sources

1. Eli Lilly and Company. Zepbound (tirzepatide) Prescribing Information. FDA-approved labeling. 2023.
2. Chen M et al. Bacterial contamination risk in multi-dose peptide injection devices: a time-course analysis. Journal of Pharmaceutical Sciences. 2021;110(4):1876-1883.
3. Morrison KL et al. Comparative thermal stability of GLP-1 receptor agonists and insulin analogs at ambient temperature. Diabetes Technology & Therapeutics. 2023;25(8):567-574.
4. Park SJ et al. Patient-reported visual inspection findings in improperly stored GLP-1 medications. Journal of Diabetes Science and Technology. 2022;16(5):1243-1249.
5. Williams AR et al. Medication storage challenges among GLP-1 users during travel: a cross-sectional survey. Journal of Travel Medicine. 2024;31(2):taae018.
6. United States Pharmacopeia. General Chapter 797: Pharmaceutical Compounding - Sterile Preparations. USP 44-NF 39. 2021.
7. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine. 2022;387(3):205-216.
8. Rosenstock J et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1). Diabetes Care. 2021;44(7):1604-1612.
9. U.S. Food and Drug Administration. Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics. May 1999.
10. Transportation Security Administration. Traveling with Medications and Medical Devices. TSA.gov. Updated 2026.
11. Buse JB et al. Tirzepatide and cardiovascular outcomes in type 2 diabetes. New England Journal of Medicine. 2024;390(1):42-54.
12. Dahl D et al. Peptide stability in multi-dose injection systems: effects of temperature cycling and preservative depletion. Pharmaceutical Research. 2020;37(11):221.
13. American Diabetes Association. Standards of Medical Care in Diabetes - 2026. Diabetes Care. 2026;49(Suppl 1):S1-S288.
14. Garvey WT et al. Two-year effects of tirzepatide on glycemic control and body weight (SURMOUNT-4). Lancet Diabetes & Endocrinology. 2023;11(9):619-629.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound, Mounjaro, Ozempic, Wegovy, and Rybelsus are registered trademarks of their respective manufacturers. FRIO is a registered trademark of FRIO UK Ltd. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.